Recent Updates
Recently added Catalysts
CHRS Positive Sentiment Score: 70/100

Coherus BioSciences Announces New Employment Inducement Grants

Friday, December 22, 2023 1 min read
Key Takeaway: Coherus BioSciences has announced the granting of stock options to five newly hired employees as part of its employment incentive plan. Effective December 20, 2023, the total of 192,000 shares will be available for purchase at an exercise price of $1.94, equal to the closing price on that date. One executive vice president received an option for 150,000 shares, while four non-officer employees share the remaining options. This initiative is aimed at inducing skilled professionals to join the company.

Market Sentiment Analysis

POSITIVE FACTORS

  • Coherus BioSciences has successfully attracted new talent.
  • The stock options incentivize new employees, which may enhance company performance.
  • The exercise price of $1.94 aligns with current market value, promoting fairness.

Full Press Release Details

REDWOOD CITY, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective December 20, 2023, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 192,000 shares of the common stock of the Company to five newly hired employees with a per share exercise price of $1.94, the closing trading price on the grant date. One Executive Vice President level executive was granted an option to purchase 150,000 shares; and four additional non-officer employees were granted options to purchase an aggregate of 42,000 shares.
The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan, which was approved by the Company’s board of directors in June 2016 under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the Company.
Coherus BioSciences Contact Information:
Jami Taylor, Head of Investor Relations
Coherus BioSciences, Inc.

Frequently Asked Questions

When were stock options granted by Coherus BioSciences?

Stock options were granted on December 20, 2023.

How many shares were granted to new employees at Coherus?

A total of 192,000 shares were granted to five new employees.

What is the exercise price for the granted stock options?

The exercise price for the options is $1.94 per share.

Who approved the 2016 Employment Commencement Incentive Plan?

The plan was approved by Coherus's board of directors in June 2016.

What was the purpose of granting the stock options?

The options were granted to attract new employees to the Company.

Tags: CHRS Viatris Investor Conferences Healthcare Coherus BioSciences employment stock options new hires
Last updated: Dec 22, 2023